PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs

Running, not enrolling · Not applicable

Conditions studied: Benign Prostatic Hyperplasia, Localized Prostate Cancer

In brief

The goal of this clinical trial is to assess the performance and safety of the AQUABEAM Robotic System for the resection and removal of prostate tissue in patients experiencing lower urinary tract symptoms (LUTS) and are diagnosed with localized prostate cancer. Participants will go through baseline and follow up assessments up to 12 months.

Key facts

Study ID

NCT06051942

Run by

PROCEPT BioRobotics

People needed

125

Starts

2022-11-22

Expected to finish

2027-03-01

Last updated by the study team

2026-01-28

Who can join

Age: any, up to 80. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• International Prostate Symptom Score (IPSS) ≥ 8
• Gleason Grade Group 1-3
• Prostate-specific Antigen (PSA) ≤20ng/mL
• Cancer stage less than or equal to T2c

You may not qualify if…

• Patients with previous surgical treatment of benign prostatic hyperplasia
• MRI evidence of extracapsular extension of cancer
• Any severe illness that would prevent complete study participation or confound study results

Where it is running

• San Diego Clinical Trials — La Mesa, California, United States
• Endeavour Health (NorthShore University HealthSystem) — Glenview, Illinois, United States
• Potomac Urology Center — Alexandria, Virginia, United States
• The Chinese University of Hong Kong — Hong Kong, Hong Kong
• American University of Beirut — Beirut, Lebanon
• Tauranga Urology Research Ltd — Tauranga, New Zealand

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.